NeuroPace Future Growth
Future criteria checks 1/6
NeuroPace is forecast to grow earnings and revenue by 23.3% and 17.9% per annum respectively. EPS is expected to grow by 27.2% per annum. Return on equity is forecast to be -307.9% in 3 years.
Key information
23.3%
Earnings growth rate
27.2%
EPS growth rate
| Medical Equipment earnings growth | 17.4% |
| Revenue growth rate | 17.9% |
| Future return on equity | -307.9% |
| Analyst coverage | Good |
| Last updated | 15 Oct 2024 |
Recent future growth updates
Recent updates
NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03
Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 107 | -22 | -7 | -5 | 6 |
| 12/31/2025 | 89 | -30 | -18 | -15 | 7 |
| 12/31/2024 | 77 | -32 | -21 | -20 | 7 |
| 6/30/2024 | 72 | -30 | -17 | -17 | N/A |
| 3/31/2024 | 69 | -32 | -18 | -18 | N/A |
| 12/31/2023 | 65 | -33 | -20 | -20 | N/A |
| 9/30/2023 | 60 | -38 | -24 | -24 | N/A |
| 6/30/2023 | 55 | -42 | -29 | -29 | N/A |
| 3/31/2023 | 49 | -46 | -36 | -35 | N/A |
| 12/31/2022 | 46 | -47 | -37 | -37 | N/A |
| 9/30/2022 | 44 | -47 | -38 | -37 | N/A |
| 6/30/2022 | 43 | -43 | -35 | -35 | N/A |
| 3/31/2022 | 45 | -39 | -31 | -30 | N/A |
| 12/31/2021 | 45 | -36 | -25 | -25 | N/A |
| 9/30/2021 | 45 | -30 | -23 | -23 | N/A |
| 6/30/2021 | 47 | -26 | -24 | -24 | N/A |
| 3/31/2021 | 42 | -26 | -21 | -21 | N/A |
| 12/31/2020 | 41 | -24 | -22 | -22 | N/A |
| 12/31/2019 | 37 | -30 | -25 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NPCE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NPCE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NPCE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NPCE's revenue (17.9% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: NPCE's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NPCE is forecast to be unprofitable in 3 years.